Feron O - Search Results

1

Delivery of siRNA targeting tumor metabolism using non-covalent PEGylated chitosan nanoparticles: Identification of an optimal combination of ligand structure, linker and grafting method.

Corbet C, Ragelle H, Pourcelle V, Vanvarenberg K, Marchand-Brynaert J, Préat V, Feron O. Corbet C, et al. Among authors: feron o. J Control Release. 2016 Feb 10;223:53-63. doi: 10.1016/j.jconrel.2015.12.020. Epub 2015 Dec 14. J Control Release. 2016. PMID: 26699426

2

Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation.

Danhier F, Lecouturier N, Vroman B, Jérôme C, Marchand-Brynaert J, Feron O, Préat V. Danhier F, et al. Among authors: feron o. J Control Release. 2009 Jan 5;133(1):11-7. doi: 10.1016/j.jconrel.2008.09.086. Epub 2008 Oct 9. J Control Release. 2009. PMID: 18950666

3

Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel.

Danhier F, Vroman B, Lecouturier N, Crokart N, Pourcelle V, Freichels H, Jérôme C, Marchand-Brynaert J, Feron O, Préat V. Danhier F, et al. Among authors: feron o. J Control Release. 2009 Dec 3;140(2):166-73. doi: 10.1016/j.jconrel.2009.08.011. Epub 2009 Aug 20. J Control Release. 2009. PMID: 19699245

4

To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery.

Danhier F, Feron O, Préat V. Danhier F, et al. Among authors: feron o. J Control Release. 2010 Dec 1;148(2):135-46. doi: 10.1016/j.jconrel.2010.08.027. Epub 2010 Aug 24. J Control Release. 2010. PMID: 20797419 Review.

5

Design and development of polymeric nanoparticles for targeted delivery of nucleic acid-based therapeutics to tumor sites.

Le Breton A, Préat V, Feron O. Le Breton A, et al. Among authors: feron o. Drug Discov Today. 2010 Sep 28. doi: 10.1016/j.drudis.2010.09.003. Online ahead of print. Drug Discov Today. 2010. PMID: 20887799 No abstract available.

6

3D systems delivering VEGF to promote angiogenesis for tissue engineering.

des Rieux A, Ucakar B, Mupendwa BP, Colau D, Feron O, Carmeliet P, Préat V. des Rieux A, et al. Among authors: feron o. J Control Release. 2011 Mar 30;150(3):272-8. doi: 10.1016/j.jconrel.2010.11.028. Epub 2010 Dec 3. J Control Release. 2011. PMID: 21130820

7

Antitumoral and antimetastatic effect of antiangiogenic plasmids in B16 melanoma: Higher efficiency of the recombinant disintegrin domain of ADAM 15.

Daugimont L, Vandermeulen G, Defresne F, Bouzin C, Mir LM, Bouquet C, Feron O, Préat V. Daugimont L, et al. Among authors: feron o. Eur J Pharm Biopharm. 2011 Aug;78(3):314-9. doi: 10.1016/j.ejpb.2011.02.001. Epub 2011 Feb 18. Eur J Pharm Biopharm. 2011. PMID: 21316447

8

Delivery of soluble VEGF receptor 1 (sFlt1) by gene electrotransfer as a new antiangiogenic cancer therapy.

Verrax J, Defresne F, Lair F, Vandermeulen G, Rath G, Dessy C, Préat V, Feron O. Verrax J, et al. Among authors: feron o. Mol Pharm. 2011 Jun 6;8(3):701-8. doi: 10.1021/mp100268t. Epub 2011 May 13. Mol Pharm. 2011. PMID: 21548585

9

LDV peptidomimetics equipped with biotinylated spacer-arms: synthesis and biological evaluation on CCRF-CEM cell line.

Gérard E, Meulle A, Feron O, Marchand-Brynaert J. Gérard E, et al. Among authors: feron o. Bioorg Med Chem Lett. 2012 Jan 1;22(1):586-90. doi: 10.1016/j.bmcl.2011.10.078. Epub 2011 Oct 31. Bioorg Med Chem Lett. 2012. PMID: 22101134

10

Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles.

Danhier F, Pourcelle V, Marchand-Brynaert J, Jérôme C, Feron O, Préat V. Danhier F, et al. Among authors: feron o. Methods Enzymol. 2012;508:157-75. doi: 10.1016/B978-0-12-391860-4.00008-2. Methods Enzymol. 2012. PMID: 22449925

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

273 results

Search Page

Filters